Evotec Completes Divesture of Chemical Development Business. For full details, please click on the link to the press release below.
This divestiture allows Evotec to focus even more on its strategy to become an emerging pharmaceutical company providing high-value research results to its partners through discovery collaborations and partnering of preclinical and clinical programs developed internally.
If you have an enquiry relating to Chemical & Pharmaceutical Development services, please contact a representative of Aptuit Inc., details of which can be found on the Aptuit website at http://www.aptuit.com where you will be able to find further information and full contact details.
[search2]
[search2]
